Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Multi-Cohort, Phase II Study of Ivonescimab in Combination With GEMOX Chemotherapy as Neoadjuvant and Conversion Therapy for Biliary Tract Cancer

NCT07854600 is registered in ClinicalTrials.gov with Haitao Zhao, MD as lead sponsor.

NCT NCT07854600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Multi-Cohort, Phase II Study of Ivonescimab in Combination With GEMOX Chemotherapy as Neoadjuvant and Conversion Therapy for Biliary Tract Cancer
Lead sponsor
Haitao Zhao, MD
Phase
Phase 2
Overall status
Recruiting
Start date
October 31, 2026
Completion date
December 31, 2029
Enrollment
87 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer (btc)